The future of medical chart review: frictionless, scalable, and trustworthy
We've built the AI layer for chart review - physician-level reasoning that unlocks value and improves care.
Trusted by




The future of medical chart review: frictionless, scalable, and trustworthy
We've built the AI layer for chart review - physician-level reasoning that unlocks value and improves care.
Trusted by




The future of medical chart review: frictionless, scalable, and trustworthy
We've built the AI layer for chart review - physician-level reasoning that unlocks value and improves care.
Trusted by




The future of medical chart review: frictionless, scalable, and trustworthy
We've built the AI layer for chart review - physician-level reasoning that unlocks value and improves care.
Trusted by




How Layer Health Works
We’ve built an enterprise LLM platform to flexibly and scalably power any use case requiring chart review
from clinical registries, to custom quality measurement and clinical pathways.
How Layer Health Works
We’ve built an enterprise LLM platform to flexibly and scalably power any use case requiring chart review
from clinical registries, to custom quality measurement and clinical pathways.
How Layer Health Works
We’ve built an enterprise LLM platform to flexibly and scalably power any use case requiring chart review
from clinical registries, to custom quality measurement and clinical pathways.
Rich, longitudinal patient charts
Rich, longitudinal patient charts
Rich, longitudinal patient charts
CT report
ED note
Oncology note
Social worker note
Pathology Report
CT report
ED note
Oncology note
Social worker note
Pathology Report




AI powered chart review
Support any use case
Answers to complex clinical questions - grounded in evidence.
Answers to complex clinical questions - grounded in evidence.



Clinical Registry Automation
Custom Quality Measurement
Intelligent Clinical Pathways
Stage III
Discontinued pembro in May
Adverse event was pneumonitis
Oncology progress note
HFrEF
Cardiomyopathy secondary
to alcohol
EF 30%
Struggles with stairs
Cardiology note
Residual microscopic disease
PD-L1 positive, EGFR negative
Invasive adenocarcinoma
Pathology report
How We Are Different
1
Accuracy You Can Trust
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
2
Supercharge High-Value Use Cases
P
3
Configurable & Extensible
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
Hypodensity L MCA territory
CT Head Report
Consistent with ischemic stroke. No hemorrhage
Validated
Etiology: Ischemic
What was the etiology of the stroke?

How We Are Different
1
Accuracy You Can Trust
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
2
Supercharge High-Value Use Cases
P
3
Configurable & Extensible
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
Hypodensity L MCA territory
CT Head Report
Consistent with ischemic stroke. No hemorrhage
Validated
Etiology: Ischemic
What was the etiology of the stroke?

How We Are Different
1
Accuracy You Can Trust
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
2
Supercharge High-Value Use Cases
P
3
Configurable & Extensible
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
Hypodensity L MCA territory
CT Head Report
Consistent with ischemic stroke. No hemorrhage
Validated
Etiology: Ischemic
What was the etiology of the stroke?

How We Are Different
1
Accuracy You Can Trust
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.
2
Supercharge High-Value Use Cases
P
3
Configurable & Extensible
Purpose built for healthcare to reason longitudinally across patient charts. Validated to surpass human performance.




Ready to revolutionize chart review?
Ready to revolutionize chart review?
Enterprise-grade security and compliance.


Enterprise-grade security and compliance.


Enterprise-grade security and compliance.


Enterprise-grade security and compliance.

